SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

Other languages Shenzhen Kangtai Biological Products Co., Ltd.

Equities

300601

CNE100002Q33

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
19.51 ^CNY	-1.86%		-2.30%	-28.14%

Jan. 10	Kangtai Biological Forecasts Swing to Profit in 2023	MT
2023	Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kangtai Biological Forecasts Swing to Profit in 2023	Jan. 10
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26
Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemented (A Shares) for 2023, Payable on 13 October 2023	23-10-09
Shenzhen Kangtai Biological Products Co., Ltd. Approves 2023 Interim Cash Dividend	23-09-27
Kangtai Signs Deal to Distribute Varicella Vaccine in Pakistan, India	23-09-20
Shenzhen Kangtai Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023	23-08-27
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25
Kangtai Biological Partners With Indian Drugmaker to Distribute Pneumococcal Vaccine	23-05-31
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23
Shenzhen Kangtai Biological sees 2022 net loss on weaker COVID shot demand	23-01-10
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27
Shenzhen Kangtai Biological Products Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 14, 2022.	22-10-12
China's CanSinoBIO H1 revenue drops on weaker COVID shot demand	22-08-28
Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18
Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.	22-08-17
Kangtai Biological Sees Up to 70% Profit Slump in H1	22-07-25
Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on 2 June 2022	22-05-27
Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Year 2021	22-05-23
Kangtai Biological’s 2021 Profit Surges 86% on Robust Sales	22-04-28
Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend Proposal for 2021	22-04-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shenzhen Kangtai Biological Products Co., Ltd.

Equities

300601

CNE100002Q33

Other languages

Filters